Free Trial

Albemarle (ALB) Stock Forecast & Price Target

Albemarle logo
$108.53 -1.02 (-0.93%)
(As of 12:20 PM ET)

Albemarle - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
15
Buy
6

Based on 22 Wall Street analysts who have issued ratings for Albemarle in the last 12 months, the stock has a consensus rating of "Hold." Out of the 22 analysts, 1 has given a sell rating, 15 have given a hold rating, and 6 have given a buy rating for ALB.

Consensus Price Target

$114.47
5.48% Upside
According to the 22 analysts' twelve-month price targets for Albemarle, the average price target is $114.47. The highest price target for ALB is $170.00, while the lowest price target for ALB is $78.00. The average price target represents a forecasted upside of 5.48% from the current price of $108.53.
Get the Latest News and Ratings for ALB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Albemarle and its competitors.

Sign Up

ALB Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
11 Buy rating(s)
Hold
15 Hold rating(s)
15 Hold rating(s)
15 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$114.47$117.60$122.60$228.50
Forecasted Upside5.48% Upside21.95% Upside35.47% Upside80.50% Upside
Consensus Rating
Hold
Hold
Hold
Hold

ALB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Albemarle Stock vs. The Competition

TypeAlbemarleBasic Materials CompaniesS&P 500
Consensus Rating Score
2.23
2.76
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside5.66% Upside121.39% Upside9.87% Upside
News Sentiment Rating
Neutral News

See Recent ALB News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/12/2024Royal Bank of Canada
4 of 5 stars
 Boost TargetOutperform ➝ Outperform$108.00 ➝ $133.00+26.27%
11/12/2024KeyCorp
3 of 5 stars
 Lower TargetOverweight ➝ Overweight$132.00 ➝ $127.00+14.94%
11/8/2024Oppenheimer
3 of 5 stars
 Lower TargetOutperform ➝ Outperform$171.00 ➝ $170.00+72.87%
10/25/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$85.00 ➝ $79.00-16.99%
10/8/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Sison
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$100.00 ➝ $110.00+9.22%
8/28/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$190.00 ➝ $170.00+90.99%
Financial Prophecy (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.
8/19/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$115.00 ➝ $78.00-1.71%
8/16/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$105.00 ➝ $80.00+1.88%
8/8/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$95.00 ➝ $90.00+13.82%
8/6/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Isaacson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetSector Perform ➝ Sector Perform$135.00 ➝ $85.00+4.04%
8/5/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Kallo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/2/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$135.00 ➝ $126.00+48.64%
7/31/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$128.00 ➝ $103.00+10.48%
7/31/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Castanos-Moll
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$160.00 ➝ $83.00-10.28%
7/17/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seshadri
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
7/17/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$95.00-3.62%
7/12/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$137.00 ➝ $100.00+2.22%
7/9/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$124.00 ➝ $109.00+20.48%
3/15/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$168.00 ➝ $162.00+29.53%
3/8/2024Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$145.00+18.19%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoveragePeer Perform
1/29/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$220.00 ➝ $130.00+8.48%
11/7/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$265.00 ➝ $180.00+48.06%
8/3/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderperform ➝ Underperform$163.00 ➝ $185.00-8.82%
2/21/2023CICC Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform
1/26/2023Piper Sandler Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight
11/28/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight$145.00 ➝ $155.00-41.51%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:36 PM ET.


ALB Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Albemarle is $114.47, with a high forecast of $170.00 and a low forecast of $78.00.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last twelve months. There is currently 1 sell rating, 15 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ALB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.

According to analysts, Albemarle's stock has a predicted upside of 5.48% based on their 12-month stock forecasts.

Albemarle has been rated by research analysts at Evercore ISI, KeyCorp, Oppenheimer, Robert W. Baird, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.

Analysts like Albemarle less than other "basic materials" companies. The consensus rating for Albemarle is Hold while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how ALB compares to other companies.


This page (NYSE:ALB) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners